Compounded ketotifen eye drops prepared for prescriber-guided, individualized ophthalmic allergy or mast cell-related care planning. Prescription required.
Ketotifen Eye Drops are a compounded ophthalmic formulation prepared by HDRx according to individualized prescriber specifications. A valid prescription from a licensed healthcare provider is required.
Ketotifen is described in pharmacology literature as an antiallergic medication with antihistamine activity and mast cell–stabilizing properties. These mechanisms are referenced in clinical discussions involving immune responses and allergic conditions affecting the eyes.
A compounded ophthalmic preparation allows healthcare providers to request specific concentrations or formulations when a commercially available option may not meet the needs of an individualized care plan.
Compounding may also support patients who require customized strengths or specialized ophthalmic preparations.
Ketotifen has been referenced in research discussions involving allergic conditions and mast cell activity, including scenarios where providers are exploring approaches to complex hypersensitivity responses.
To learn more about ketotifen and mast cell stabilization, see our ketotifen compounding page, our article on compounded ketotifen and mast cell activation syndrome, and our overview of mast cell stabilizers used in compounding pharmacy practice.
Compounded medications are not FDA-approved and are prepared to meet specific patient needs as directed by a licensed healthcare provider. Patients should consult their prescriber to determine whether this formulation is appropriate for their individual care plan.
